OrganiGram Holdings Inc. (OGI.TO)
CAD 2.1
(-7.89%)
CAD 2.1
(-7.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 149.2 Million CAD | 2.33% |
| 2022 | 145.8 Million CAD | 84.19% |
| 2021 | 79.16 Million CAD | -8.79% |
| 2020 | 86.79 Million CAD | 7.94% |
| 2019 | 80.41 Million CAD | 546.98% |
| 2018 | 12.42 Million CAD | 117.53% |
| 2017 | 5.71 Million CAD | -6.76% |
| 2016 | 6.12 Million CAD | 521.04% |
| 2015 | 986.67 Thousand CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 37.62 Million CAD | 3.22% |
| 2024 Q3 | 41.06 Million CAD | 9.12% |
| 2024 Q1 | 36.45 Million CAD | -20.82% |
| 2023 Q2 | 39.49 Million CAD | -8.84% |
| 2023 Q3 | 32.78 Million CAD | -16.99% |
| 2023 Q4 | 46.04 Million CAD | 40.43% |
| 2023 Q1 | 43.32 Million CAD | -4.75% |
| 2023 FY | 149.2 Million CAD | 2.33% |
| 2022 Q4 | 45.48 Million CAD | 19.32% |
| 2022 Q3 | 38.11 Million CAD | 19.72% |
| 2022 Q2 | 31.83 Million CAD | 4.8% |
| 2022 FY | 145.8 Million CAD | 84.19% |
| 2022 Q1 | 30.37 Million CAD | 22.17% |
| 2021 Q2 | 14.64 Million CAD | -24.25% |
| 2021 Q3 | 20.32 Million CAD | 38.8% |
| 2021 Q4 | 24.86 Million CAD | 22.34% |
| 2021 Q1 | 19.33 Million CAD | -5.24% |
| 2021 FY | 79.16 Million CAD | -8.79% |
| 2020 Q3 | 18.02 Million CAD | -22.39% |
| 2020 Q4 | 20.4 Million CAD | 13.2% |
| 2020 FY | 86.79 Million CAD | 7.94% |
| 2020 Q1 | 25.15 Million CAD | 54.41% |
| 2020 Q2 | 23.22 Million CAD | -7.68% |
| 2019 Q4 | 16.29 Million CAD | -34.18% |
| 2019 Q1 | 12.43 Million CAD | 434.55% |
| 2019 Q3 | 24.75 Million CAD | -8.11% |
| 2019 FY | 80.41 Million CAD | 546.98% |
| 2019 Q2 | 26.93 Million CAD | 116.53% |
| 2018 Q3 | 3.72 Million CAD | 1.01% |
| 2018 FY | 12.42 Million CAD | 117.53% |
| 2018 Q4 | 2.32 Million CAD | -37.55% |
| 2018 Q2 | 3.68 Million CAD | 37.32% |
| 2018 Q1 | 2.68 Million CAD | 25.14% |
| 2017 Q1 | 2.23 Million CAD | 19.55% |
| 2017 Q2 | -581.16 Thousand CAD | -126.05% |
| 2017 Q3 | 1.91 Million CAD | 429.94% |
| 2017 Q4 | 2.14 Million CAD | 11.95% |
| 2017 FY | 5.71 Million CAD | -6.76% |
| 2016 Q3 | 1.8 Million CAD | 26.75% |
| 2016 Q4 | 1.86 Million CAD | 3.27% |
| 2016 FY | 6.12 Million CAD | 521.04% |
| 2016 Q1 | 1.02 Million CAD | 52.38% |
| 2016 Q2 | 1.42 Million CAD | 38.48% |
| 2015 Q2 | 67.97 Thousand CAD | 417.99% |
| 2015 Q1 | 13.12 Thousand CAD | 0.0% |
| 2015 Q4 | 675.53 Thousand CAD | 193.64% |
| 2015 FY | 986.67 Thousand CAD | 0.0% |
| 2015 Q3 | 230.05 Thousand CAD | 238.46% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aurora Cannabis Inc. | 270.28 Million CAD | 44.796% |
| Avicanna Inc. | 16.79 Million CAD | -788.577% |
| Avant Brands Inc. | 26.34 Million CAD | -466.373% |
| Cardiol Therapeutics Inc. | - CAD | -Infinity% |
| Crescita Therapeutics Inc. | 17.52 Million CAD | -751.531% |
| Knight Therapeutics Inc. | 328.19 Million CAD | 54.538% |
| MediPharm Labs Corp. | 33.06 Million CAD | -351.289% |
| Canopy Growth Corporation | 297.14 Million CAD | 49.787% |
| Willow Biosciences Inc. | 1.17 Million CAD | -12630.823% |
| Auxly Cannabis Group Inc. | 101.07 Million CAD | -47.614% |